Cargando…

Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico

BACKGROUND: In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-related quality of life (HRQL) is scarce. We aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Doubova, Svetlana V., Terreros-Muñoz, Eduardo, Delgado-Lòpez, Nancy, Montaño-Figueroa, Efreen Horacio, Infante-Castañeda, Claudia, Pérez-Cuevas, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353677/
https://www.ncbi.nlm.nih.gov/pubmed/32650770
http://dx.doi.org/10.1186/s12913-020-05498-7
_version_ 1783557932386877440
author Doubova, Svetlana V.
Terreros-Muñoz, Eduardo
Delgado-Lòpez, Nancy
Montaño-Figueroa, Efreen Horacio
Infante-Castañeda, Claudia
Pérez-Cuevas, Ricardo
author_facet Doubova, Svetlana V.
Terreros-Muñoz, Eduardo
Delgado-Lòpez, Nancy
Montaño-Figueroa, Efreen Horacio
Infante-Castañeda, Claudia
Pérez-Cuevas, Ricardo
author_sort Doubova, Svetlana V.
collection PubMed
description BACKGROUND: In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-related quality of life (HRQL) is scarce. We aimed to evaluate experiences with health care and HRQL of patients with HMs and the association between these patient-reported measures. METHODS: We conducted a cross-sectional survey in two public oncology hospitals in Mexico City. The study included outpatient cancer patients aged ≥18 years with a diagnosis of leukemia, lymphoma, or multiple myeloma. We used a patient-centered quality of cancer care questionnaire to assess patient experiences with receiving 1) timely care; 2) clear information; 3) information for treatment decision-making; 4) care to address biopsychosocial needs; and 5) respectful and coordinated care. We applied the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) to measure HRQL. We performed a multiple linear regression to evaluate the association between patient-reported experiences (independent variables) and the QLQ-C30 summary score (dependent variable). RESULTS: Of the 515 participating HM patients, 46.6% had lymphoma, 34% leukemia, and 19.4% multiple myeloma; 70.9% were at advanced stages or at high risk. Additionally, 15.1% had anxiety and 12.8% had depression. Over one third (35.9%) reported receiving clear information, 28.5% timely care, 20.6% information for treatment decision-making, 23.7% care that addressed their biopsychosocial needs, and 31% respectful and coordinated care. The mean QLQ-C30 summary score was 71.9 points. Timely care, clear information, and care that addresses biopsychosocial needs were associated with higher HRQL. CONCLUSIONS: Health care services for HM patients at public oncology hospitals in Mexico need improvement. Notably, providing timely care, clear information, and care that addresses patients’ biopsychosocial needs can increase the likelihood of better HRQL. Health care providers should measure and improve the experiences of HM patients with health care.
format Online
Article
Text
id pubmed-7353677
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73536772020-07-14 Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico Doubova, Svetlana V. Terreros-Muñoz, Eduardo Delgado-Lòpez, Nancy Montaño-Figueroa, Efreen Horacio Infante-Castañeda, Claudia Pérez-Cuevas, Ricardo BMC Health Serv Res Research Article BACKGROUND: In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-related quality of life (HRQL) is scarce. We aimed to evaluate experiences with health care and HRQL of patients with HMs and the association between these patient-reported measures. METHODS: We conducted a cross-sectional survey in two public oncology hospitals in Mexico City. The study included outpatient cancer patients aged ≥18 years with a diagnosis of leukemia, lymphoma, or multiple myeloma. We used a patient-centered quality of cancer care questionnaire to assess patient experiences with receiving 1) timely care; 2) clear information; 3) information for treatment decision-making; 4) care to address biopsychosocial needs; and 5) respectful and coordinated care. We applied the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) to measure HRQL. We performed a multiple linear regression to evaluate the association between patient-reported experiences (independent variables) and the QLQ-C30 summary score (dependent variable). RESULTS: Of the 515 participating HM patients, 46.6% had lymphoma, 34% leukemia, and 19.4% multiple myeloma; 70.9% were at advanced stages or at high risk. Additionally, 15.1% had anxiety and 12.8% had depression. Over one third (35.9%) reported receiving clear information, 28.5% timely care, 20.6% information for treatment decision-making, 23.7% care that addressed their biopsychosocial needs, and 31% respectful and coordinated care. The mean QLQ-C30 summary score was 71.9 points. Timely care, clear information, and care that addresses biopsychosocial needs were associated with higher HRQL. CONCLUSIONS: Health care services for HM patients at public oncology hospitals in Mexico need improvement. Notably, providing timely care, clear information, and care that addresses patients’ biopsychosocial needs can increase the likelihood of better HRQL. Health care providers should measure and improve the experiences of HM patients with health care. BioMed Central 2020-07-10 /pmc/articles/PMC7353677/ /pubmed/32650770 http://dx.doi.org/10.1186/s12913-020-05498-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Doubova, Svetlana V.
Terreros-Muñoz, Eduardo
Delgado-Lòpez, Nancy
Montaño-Figueroa, Efreen Horacio
Infante-Castañeda, Claudia
Pérez-Cuevas, Ricardo
Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
title Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
title_full Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
title_fullStr Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
title_full_unstemmed Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
title_short Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
title_sort experiences with health care and health-related quality of life of patients with hematologic malignancies in mexico
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353677/
https://www.ncbi.nlm.nih.gov/pubmed/32650770
http://dx.doi.org/10.1186/s12913-020-05498-7
work_keys_str_mv AT doubovasvetlanav experienceswithhealthcareandhealthrelatedqualityoflifeofpatientswithhematologicmalignanciesinmexico
AT terrerosmunozeduardo experienceswithhealthcareandhealthrelatedqualityoflifeofpatientswithhematologicmalignanciesinmexico
AT delgadolopeznancy experienceswithhealthcareandhealthrelatedqualityoflifeofpatientswithhematologicmalignanciesinmexico
AT montanofigueroaefreenhoracio experienceswithhealthcareandhealthrelatedqualityoflifeofpatientswithhematologicmalignanciesinmexico
AT infantecastanedaclaudia experienceswithhealthcareandhealthrelatedqualityoflifeofpatientswithhematologicmalignanciesinmexico
AT perezcuevasricardo experienceswithhealthcareandhealthrelatedqualityoflifeofpatientswithhematologicmalignanciesinmexico